Essential points to remember are that GLP-1 and GIP analogues may be beneficial for people with ASCVD and/or obesity, alongside T2DM as this drug class has shown benefit in improving cardiovascular outcomes and reducing weight, both of which we know are intrinsically linked to T2DM
These symptoms may include mental health, cognitive issues, cardiovascular health, gastrointestinal issues, pain syndromes, insomnia, headaches, and post exertional malaise
Weight Loss Is Always About More Than One Factor Medication can influence appetite and create opportunities for progress, but lasting results rely on habits, accountability and support
How can patients avoid this type of mistake
Patients use bacteriostatic water for injections, irrigation, washing, and other uses
Through a time-limited initiative known as the Medicare GLP-1 Bridge, eligible Medicare beneficiaries will soon be able to obtain certain GLP-1 drugs for just $50 per month, a significant reduction from current market prices that often exceed $1,000 monthly." Read the full article here: To view or add a comment, sign in Increase access to care is music to my ears